Breast Cancer

Study shows the recurrence rate was within the expected range for breast cancer survivors receiving spironolactone and those who did not.

A new test may help direct treatments for patients with rare breast cancer mutations.

It may take cells in different stages of development to cause breast cancer to progress and spread, according to recent research published in eLife.

Figuring out how to target vulnerable cells in breast cancer tumors can help treat the disease more effectively.

In a phase 3 clinical trial, oral paclitaxel was found to be just as effective intravenous paclitaxel in metastatic breast cancer.

The current study found no link between personal use of permanent hair dye and the risk of most cancers or cancer-related mortality.

Oral chemotherapy may be an important option for patients during the COVID-19 pandemic, as it would allow them to receive treatment at home.

Women who typically have a better prognosis in the primary breast cancer setting experienced worse survival after a second primary breast cancer.

Targeted photodynamic therapy has garnered increasing attention… because of its ability to treat tumors without surgery, chemotherapy, or radiation.

A new medication for certain rare blood cancers has now become available through a limited distribution with AllianceRx Walgreens Prime.

Targeted radiotherapy amounted to fewer deaths over a 5-year follow-up period among patients with breast cancer.

Researchers have found that gene expression associated with aging was higher in young cancer survivors who are frail and in young patients with cancer following their treatment with chemotherapy.

In addition to clinical procedures, some support groups for patients with breast cancer were also canceled as a result of the COVID-19 pandemic.

Most women with breast cancer receive treatment post surgery, such as chemotherapy, hormone therapy, and radiation. Targeted therapy is useful against cancers that have spread to distant parts of the body.

An online survey found that 44% of breast cancer survivors had care delayed during the COVID-19 pandemic.

The new analysis of the 23-year follow-up results of the trial found that screening women between 40 and 49 years of age led to a substantial and significant 25% reduction in breast cancer mortality in the first 10 years.

Because triple-negative breast cancer does not express receptors involved in most breast cancers, the investigative therapy could offer a much-needed option.

Four new subtypes of cells within triple-negative breast cancer have been uncovered, containing promising new therapeutic targets for the disease.

In the United States, these findings would translate to more than 269,000 prevented breast cancer cases and nearly 44,000 prevented cases of ovarian cancer.

Both premenopausal and postmenopausal breast cancer rates are rising globally.

Earlier results of the FAST trial, which was launched in 2004, found that reducing the number of radiotherapy fractions to 5 was feasible and safe in the short term.

The selection of an agent for hyperglycemia management requires knowledge of both the efficacy and the potential adverse effects of each possible agent, so choosing the best therapy for any given patient can be complicated.

In addition to its potential uses in cancer treatment, this novel drug delivery system could be used with magnetic resonance imaging or fluorescence imaging.

The presence of ctDNA and CTCs in the plasma of the blood of women who have undergone chemotherapy prior to surgery for the treatment of triple-negative breast cancer (TNBC) are critical indicators in the prediction of disease recurrence and disease-free survival.

Since 2015, there has been an increase in the number of specialty pharmacies in the United States due to their potential of handling the complexities of cost and appropriate drug access and administration.